# Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine

> **NCT06445205** · — · SUSPENDED · sponsor: **Lancashire Teaching Hospitals NHS Foundation Trust** · enrollment: 50 (estimated)

## Conditions studied

- Kidney Transplant Rejection
- Kidney Replacement

## Interventions

- **DIAGNOSTIC_TEST:** Mitra® device with VAMS® (volumetric absorptive microsampling) technology

## Key facts

- **NCT ID:** NCT06445205
- **Lead sponsor:** Lancashire Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-02-13
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Chief Investigator not available
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445205, "Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06445205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*